Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Patent
1995-06-05
1999-02-02
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
4241811, 4241831, 5303911, 5303913, 5303917, A61K 39395, C07K 1628, C07K 1618
Patent
active
058661271
ABSTRACT:
New compounds that bind specifically to vascular permeability factor (VPF) are used in methods of targeting these compounds, which include effector molecules that are, e.g., toxic, radioactive, or serve as marker labels, for tumor cells and the associated blood vessel endothelial cells, based on the discovery that VPF concentrates selectively in the endothelium and basement membrane lining tumor-associated blood vessels to a far greater degree than in normal vessels. By targeting VPF rather than the tumor cells themselves, the invention avoids the problems of tumor heterogeneity and diffusion distance.
REFERENCES:
patent: 4456550 (1984-06-01), Dvorak et al.
patent: 5036003 (1991-07-01), Olander et al.
Barth et al., 1990 Scientific American, 263:100 (Oct. 1990).
Bikfalvi et al., J. Cell. Physiol., 149:50-59 (1991).
Connelly et al., J. Biol. Chem., 264:20017-20024 (1989).
Connelly et al., J. Clin. Invest, 84;1470-1478 (1989).
Ferrara et al., Biochem. Biophys. Res. Comm., 161:851-858 (1989).
Goodman et al., Neurosurgery, 24:701-708 (1989).
Itoh et al., Cancer Immunol. Immunotherapy, 32:88-94 (1990).
Keck et al., Science, 246:1309-1313 (1989).
Leung et al., Science, 246:1306-1309 (1989).
Myoken et al., Proc. Nat'l Acad. Sci., 88:5819-5823 (1991).
Pastan et al., Cell, 47:641-648 (1986).
Rosenblum et al., Cancer Communications, 3(1):21-27 (1991).
Senger et al., Cancer Res., 50:1774-1778 (1990).
Senger et al. Science, 219:983-985 (1983).
Tischer et al., J. Biol Chem., 266:11947-11954 (1991).
Vaisman et al., J. Biol. Chem., 265:19461-19466 (1990).
Vitetta et al., Science, 238:1098-1104 (1987).
Waldman, Science, 252:1657-1662 (1991).
Harris, TibTech v. 1 pp. 42,-44, 1993.
Dvorak Harold F.
Senger Donald R.
Beth Israel Deaconess Medical Center
Johnson Nancy A.
Prashker David
Scheiner Toni R.
LandOfFree
Vascular permeability factor targeted compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular permeability factor targeted compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular permeability factor targeted compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114606